Platinum, 20, 129, 131, 135, 138, 144
Porous silicon nanoparticles, 63
Porphyrins, 35, 40
Positron emission tomography (PET), 2, 149,
210, 215
Prodrugs, 2
Prostate-specific membrane antigen (PSMA), 8,
9, 57, 212, 214, 216
Protein kinase A (PKA), 172
Proteins, bioluminescent, 149
fluorescent, 150
Protoporphyrin IX, 212
Q
Quantum dots (QDs), 35, 56, 83, 93, 101–105
carbon (CQDs), 196
QD605, 217
Quinoline, 4
Quinone-cyanine-7 (QCy7), 188
R
Radiative transfer equation (RTE), 13
Radiolabeled ligands, 149
Raman spectroscopy, 209
Rare-earth-doped nanoparticles (RENPs), 81,
83, 93, 101
Rayleigh–Mie scattering, 82
Reactive oxygen species (ROS), 4, 19, 38, 170,
174, 218
Receptors, 170
Reflectance spectroscopy, 210
RhoA-FRET, 173
Rhodamines, 4, 35, 38, 56, 73, 186, 195
derivative fluorescent probe (RDP), 38
S
Salicylaldehyde azine (SA), 190
Second near-infrared window (NIR-II), 81
SGM-101, 41
Silica nanoparticles, 194
Silicon drift detector (SDD), 131
Silver, 74, 131, 135
Single-photon emission computed tomography
(SPECT), 6, 149, 186, 212
Single-walled carbon nanotubes (SWCNTs),
58, 81, 83, 93, 109–113
6-(Benzo[d]thiazol-2-yl)-2-(methylamino)naphthalene, 186
Small-molecule dyes (SMDs), 81, 83
complexes (SMDCs), 83
Small-molecule dyes based organic
nanoparticles (SMDNPs), 83
Synonymously secondary Cerenkov-induced
fluorescence imaging (SCIFI), 217
T
Targeted ligands, 7
Tetratraphenylporphinesulfonate (TPPS), 40
Thiols, 19, 38, 43, 64
Thyroid, 91, 217
Time-gated fluorescence (TGF), 64
TokyoMagenta (TM), 187
Total variation (TV), 15
TPE-Gal, 193
Transcription factors, 170
Translocation sensors/assays, 170
Triple-negative breast cancers (TNBCs), 16
Troponin C, 161
Tumors, 9, 12, 17, 40, 141, 185, 211, 214
specific markers, 2
Two-photon endomicroscopy (TPEM), 210
U
Ultrasound, 149
Unnatural amino acids (UAAs), 162
Upconversion nanoparticles (UCNPs), 61
Urogenital tract cancer, 211
V
Vascular endothelial growth factor (VEGF)
receptor, 214
X
X-ray fluorescence computed tomography
(XFCT), 125, 128, 140, 144
X-ray luminescence computed tomography
(XLCT), 125, 128, 140
Y
Ytterbium (Yr), 135
Z
Zap family, 161
Zinc, ions, 161
Zinc dipicolylamine (Zn-DPA), 45
Zinc gallium oxide (ZGO), 70
Zinc phthalocyanine (ZnPc), 40
228
Index
Porous silicon nanoparticles, 63
Porphyrins, 35, 40
Positron emission tomography (PET), 2, 149,
210, 215
Prodrugs, 2
Prostate-specific membrane antigen (PSMA), 8,
9, 57, 212, 214, 216
Protein kinase A (PKA), 172
Proteins, bioluminescent, 149
fluorescent, 150
Protoporphyrin IX, 212
Q
Quantum dots (QDs), 35, 56, 83, 93, 101–105
carbon (CQDs), 196
QD605, 217
Quinoline, 4
Quinone-cyanine-7 (QCy7), 188
R
Radiative transfer equation (RTE), 13
Radiolabeled ligands, 149
Raman spectroscopy, 209
Rare-earth-doped nanoparticles (RENPs), 81,
83, 93, 101
Rayleigh–Mie scattering, 82
Reactive oxygen species (ROS), 4, 19, 38, 170,
174, 218
Receptors, 170
Reflectance spectroscopy, 210
RhoA-FRET, 173
Rhodamines, 4, 35, 38, 56, 73, 186, 195
derivative fluorescent probe (RDP), 38
S
Salicylaldehyde azine (SA), 190
Second near-infrared window (NIR-II), 81
SGM-101, 41
Silica nanoparticles, 194
Silicon drift detector (SDD), 131
Silver, 74, 131, 135
Single-photon emission computed tomography
(SPECT), 6, 149, 186, 212
Single-walled carbon nanotubes (SWCNTs),
58, 81, 83, 93, 109–113
6-(Benzo[d]thiazol-2-yl)-2-(methylamino)naphthalene, 186
Small-molecule dyes (SMDs), 81, 83
complexes (SMDCs), 83
Small-molecule dyes based organic
nanoparticles (SMDNPs), 83
Synonymously secondary Cerenkov-induced
fluorescence imaging (SCIFI), 217
T
Targeted ligands, 7
Tetratraphenylporphinesulfonate (TPPS), 40
Thiols, 19, 38, 43, 64
Thyroid, 91, 217
Time-gated fluorescence (TGF), 64
TokyoMagenta (TM), 187
Total variation (TV), 15
TPE-Gal, 193
Transcription factors, 170
Translocation sensors/assays, 170
Triple-negative breast cancers (TNBCs), 16
Troponin C, 161
Tumors, 9, 12, 17, 40, 141, 185, 211, 214
specific markers, 2
Two-photon endomicroscopy (TPEM), 210
U
Ultrasound, 149
Unnatural amino acids (UAAs), 162
Upconversion nanoparticles (UCNPs), 61
Urogenital tract cancer, 211
V
Vascular endothelial growth factor (VEGF)
receptor, 214
X
X-ray fluorescence computed tomography
(XFCT), 125, 128, 140, 144
X-ray luminescence computed tomography
(XLCT), 125, 128, 140
Y
Ytterbium (Yr), 135
Z
Zap family, 161
Zinc, ions, 161
Zinc dipicolylamine (Zn-DPA), 45
Zinc gallium oxide (ZGO), 70
Zinc phthalocyanine (ZnPc), 40
228
Index
Précédent